Connect Biopharma Holdings (CNTB)

• Market cap: $138M
• 1 day: 0.82%
• 5 days: -16.84%
• 1 month: -5%
• 3 months: -11.15%
• 6 months: 32.09%
• Year to date: -1.98%
• 1 year: 187.21%
• 5 years: -86.64%
• 10 years: -86.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62